©The Author(s) 2025.
World J Clin Oncol. Jun 24, 2025; 16(6): 107255
Published online Jun 24, 2025. doi: 10.5306/wjco.v16.i6.107255
Published online Jun 24, 2025. doi: 10.5306/wjco.v16.i6.107255
Table 3 Perioperative clinical data, n (%)
| Salvage operation | Patients (n = 28) |
| Type of surgery | |
| Laparoscopy | 7 (25.0) |
| Open | 21 (75.0) |
| Operative time, median (IQR), minutes | 245 (182.5-370.0) |
| Intraoperative blood loss, median (IQR), mL | 200 (100.0-475.0) |
| Intraoperative blood transfusion | |
| Yes | 13 (46.4) |
| No | 15 (53.6) |
| Pathological reaction | |
| PCR | 14 (50.0) |
| Non-PCR | 14 (50.0) |
| Post-operative hospitalization days, median (IQR), days | 16 (7.5-23.8) |
| Post-operative complication | |
| Present | 20 (71.4) |
| Absent | 8 (28.6) |
| Clavien-Dindo class | |
| I-II | 16 (57.1) |
| III-V | 4 (14.3) |
| Post-operative complication | |
| Liver failure | 6 (21.4) |
| Abdominal fluid | 13 (46.4) |
| Bile leakage | 4 (14.3) |
| Abdominal infection | 7 (25.0) |
| Abdominal hemorrhage | 1 (3.6) |
| Pleural effusion | 15 (53.6) |
- Citation: Zhang SB, Nashan B, Wang YL, Zhang SG. Efficacy of salvage surgery for hepatocellular carcinoma following conversion therapy. World J Clin Oncol 2025; 16(6): 107255
- URL: https://www.wjgnet.com/2218-4333/full/v16/i6/107255.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i6.107255